# Conversation Log: Triage
**Visit ID:** 99973518
**Run ID:** 8c8e33c7
**Total Calls:** 1

---
## Call 1
**Timestamp:** 2026-01-15T07:04:46.573325
**Model:** openai/gpt-5.2-2025-12-11 (structured)
**Latency:** 13195ms
**Tokens:** 2679 (Prompt: 2088, Completion: 591)

### 1. System Prompt
You are a Triage Nurse/Clinical Specialist.
Your role is to establish the "Safety Baseline" and "Clinical Context" for a patient BEFORE the doctor sees them.

## Objective
1.  **Analyze Context**: Review history to understand the patient's physiological baseline.
2.  **Set Personalized Thresholds**: Define personalized Normal and Warning ranges for vital signs based on the clinical record.
3.  **Synthesize Context**: Write a detailed patient profile summary and identify specific risks (e.g., Immunocompromised).

## Clinical Guidelines
- **Conservative Safety**: If unknown, use standard ranges.
- **Fact-Based**: Only adjust thresholds if there is clear evidence in past medical history or medications.
- **Temperature Variability**: Readings may originate from different device types (oral, temporal, axillary). Infer the likely thermometer type based on the statistical profile (Average/Min/Max).
  - If averages are consistently lower (e.g., 35.5-36.0°C), CONSIDER that this may be an axillary/peripheral measurement and ADAPT your thresholds accordingly (e.g., lower the fever threshold).
  - INFORM the doctor of this inference in your clinical context summary.
- **SpO2 Safety**: SpO2 > 95% is generally safe, high values (up to 100%) are acceptable exceptions to strict ranges and do not require warnings.


### 2. User Prompt
## Patient Context
- Age: 56
- Gender: M
- Ethnicity: Other (Hispanic/Latino)
- Chief Complaint: SHORTNESS OF BREATH

## Clinical Data
- Heart Rate (bpm): 54 values, Range 69.0-100.7 (Mean: 87.43)
- Systolic BP (mmHg): 34 values, Range 67-120 (Mean: 88)
- Diastolic BP (mmHg): 34 values, Range 39-103 (Mean: 62)
- SpO2 (%): 56 values, Range 89.1-100.0 (Mean: 95.06)
- Respiratory Rate (brpm): 55 values, Range 17.0-34.0 (Mean: 23.76)
- Temperature (°C): 30 values, Range 36.7-38.3 (Mean: 37.12)

## Medical Background
- Past Medical History: Unsp intracranial injury w LOC of unsp duration, init, Gastrostomy status, Unspecified injury of head, initial encounter, Pneumonia, unspecified organism, Calculus of kidney, Hypo-osmolality and hyponatremia, Hematuria, unspecified, Gastro-esophageal reflux disease without esophagitis, Altered mental status, unspecified, Need for assistance with personal care, Other specified health status, Abnormal findings on dx imaging of prt digestive tract, Unspecified injury of head, sequela, Palpitations, Pneumonitis due to inhalation of food and vomit, Constipation, unspecified, Gen skin eruption due to drugs and meds taken internally, Other specified postprocedural states, Age-related physical debility, Need for continuous supervision, Gastrostomy malfunction, Urinary tract infection, site not specified, I/I react d/t indwelling urethral catheter, init, I/I react d/t indwelling urethral catheter, subs, I/I react d/t indwelling urethral catheter, sequela, Acute respiratory failure with hypoxia, Sepsis, unspecified organism, Unspecified convulsions, Meconium aspiration with respiratory symptoms, Shortness of breath, Unspecified coma, Severe sepsis with septic shock, Other reduced mobility, Glasgow coma scale score 3-8, unspecified time, Glasgow coma scale score 3-8, at hospital admission, Unsp intcrn injury w LOC >24 hr w/o ret consc w surv, subs, Unsp intracranial injury w LOC of unsp duration, sequela, Pulmonary mycobacterial infection, Local-rel symptc epi w simp prt seiz,not ntrct, w/o stat epi, Paraplegia, unspecified, Obstructive hydrocephalus, Tracheostomy status, Bronchiectasis, uncomplicated

## Medications
- Medications: albuterol sulfate 2.5 mg/3 mL (0.083 %) solution for nebulization (BETA-ADRENERGIC AGENTS, INHALED, SHORT ACTING), amantadine HCL 50 mg/5 mL oral solution (ANTIPARKINSONISM DRUGS,OTHER), aspirin 81 mg chewable tablet (PLATELET AGGREGATION INHIBITORS), aspirin 81 mg chewable tablet (PLATELET AGGREGATION INHIBITORS), sodium chloride 1 gram tablet (SODIUM/SALINE PREPARATIONS), simethicone 40 mg/0.6 mL oral drops,suspension (ANTIFLATULENTS)

## Objective
1. Analyze this patient's history.
2. Define personalized safety thresholds for vital signs.
3. Write a brief Clinical Context Summary for the medical team.

### 3. Response
```json

```

---
